Healthequity Stock Technical Analysis
| HQY Stock | USD 78.35 0.93 1.17% |
As of the 10th of February, HealthEquity retains the risk adjusted performance of (0.08), and Market Risk Adjusted Performance of (0.28). HealthEquity technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
HealthEquity Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as HealthEquity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to HealthEquityHealthEquity | Build AI portfolio with HealthEquity Stock |
HealthEquity Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 119.13 | Strong Buy | 14 | Odds |
Most HealthEquity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand HealthEquity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of HealthEquity, talking to its executives and customers, or listening to HealthEquity conference calls.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. Market participants price HealthEquity higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive HealthEquity assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 8.833 | Earnings Share 2.18 | Revenue Per Share | Quarterly Revenue Growth 0.072 | Return On Assets |
HealthEquity's market price often diverges from its book value, the accounting figure shown on HealthEquity's balance sheet. Smart investors calculate HealthEquity's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since HealthEquity's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
HealthEquity 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HealthEquity's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HealthEquity.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in HealthEquity on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding HealthEquity or generate 0.0% return on investment in HealthEquity over 90 days. HealthEquity is related to or competes with Ensign, Align Technology, AptarGroup, Bio Rad, Chemed Corp, Molina Healthcare, and Revolution Medicines. HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States More
HealthEquity Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HealthEquity's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HealthEquity upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 16.72 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 2.57 |
HealthEquity Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HealthEquity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HealthEquity's standard deviation. In reality, there are many statistical measures that can use HealthEquity historical prices to predict the future HealthEquity's volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.29) |
HealthEquity February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.28) | |||
| Mean Deviation | 1.66 | |||
| Coefficient Of Variation | (921.14) | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.48 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.29) | |||
| Maximum Drawdown | 16.72 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 2.57 | |||
| Skewness | (1.03) | |||
| Kurtosis | 4.68 |
HealthEquity Backtested Returns
HealthEquity holds Efficiency (Sharpe) Ratio of -0.17, which attests that the entity had a -0.17 % return per unit of standard deviation over the last 3 months. HealthEquity exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out HealthEquity's market risk adjusted performance of (0.28), and Risk Adjusted Performance of (0.08) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.92, which attests to possible diversification benefits within a given portfolio. HealthEquity returns are very sensitive to returns on the market. As the market goes up or down, HealthEquity is expected to follow. At this point, HealthEquity has a negative expected return of -0.38%. Please make sure to check out HealthEquity's jensen alpha, as well as the relationship between the kurtosis and price action indicator , to decide if HealthEquity performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.62 |
Good predictability
HealthEquity has good predictability. Overlapping area represents the amount of predictability between HealthEquity time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HealthEquity price movement. The serial correlation of 0.62 indicates that roughly 62.0% of current HealthEquity price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.62 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 30.33 |
HealthEquity technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
HealthEquity Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for HealthEquity across different markets.
About HealthEquity Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of HealthEquity on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of HealthEquity based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on HealthEquity price pattern first instead of the macroeconomic environment surrounding HealthEquity. By analyzing HealthEquity's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of HealthEquity's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to HealthEquity specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.07 | 0.0735 | Price To Sales Ratio | 7.2 | 6.55 |
HealthEquity February 10, 2026 Technical Indicators
Most technical analysis of HealthEquity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for HealthEquity from various momentum indicators to cycle indicators. When you analyze HealthEquity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.28) | |||
| Mean Deviation | 1.66 | |||
| Coefficient Of Variation | (921.14) | |||
| Standard Deviation | 2.34 | |||
| Variance | 5.48 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.51) | |||
| Treynor Ratio | (0.29) | |||
| Maximum Drawdown | 16.72 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 2.57 | |||
| Skewness | (1.03) | |||
| Kurtosis | 4.68 |
HealthEquity February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as HealthEquity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 27,808 | ||
| Daily Balance Of Power | (0.37) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 79.57 | ||
| Day Typical Price | 79.16 | ||
| Price Action Indicator | (1.68) |
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.